Ann: Appendix 4C - quarterly, page-4

I think the progress is slow because the product is low price. They need a massive volume to make significant revenue.

They are burning cash at $1.0 per qtr and only have $1.5 cash. So I agree with elitelifestyles that a CR is most likely imminent.

The Medical Cannabis initiative appears subdued.

I have held the stock, been out, back in and currently out. I like the product and concept but just waiting to see the financial economics of the business stack up.